nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.36485/1561-6274-2020-24-6-28-39nefr-1899Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯORIGINAL ARTICLES. CLINICAL INVESTIGATIONSИспользование биомаркеров миокардиального повреждения и сердечной недостаточности в предиктивной и ранней диагностике острого повреждения почек при остром коронарном синдромеАpplication of myocardial damage and heart failure biomarkers in preventive and early diagnosis of aki in acute coronary syndromehttps://orcid.org/0000-0003-4528-9373ВоробьевЕ. А.VorobyevE. A.

Воробьев Евгений Александрович, врач-нефролог

197022, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54Тел.: +7(952)206-18-42 

Eugene A. Vorobyev, nephrologist

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(952)206-18-42 

vorobyeveval@gmail.comhttps://orcid.org/0000-0001-7265-7392ГалкинаО. В.GalkinaO. V.

Галкина Ольга Владимировна, канд. биол. наук, лаборатория биохимического гомеостаза

197022, Санкт-Петербург. ул. Л. Толстого, д. 17, корп. 54Тел.: +7(812)3386901 

Olga V. Galkina, PhD in Biology, Laboratory of Biochemical Homeostasis, Head

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(812)3386901 

ovgalkina@mail.ruhttps://orcid.org/0000-0001-8491-7016ЗубинаИ. М.ZubinaI. M.

Зубина Ирина Михайловна, канд. биол. наук, лаборатория биохимического гомеостаза

197022, Санкт-Петербург. ул. Л. Толстого, д. 17, корп. 54Тел.: +7(812)3386901 

Irina M. Zubina, PhD in Biology, Laboratory of Biochemical Homeostasis

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(812)3386901 

zubina@list.ruhttps://orcid.org/0000-0003-1969-1959БогдановаЕ. О.BogdanovaE. O.

Богданова Евдокия Олеговна, канд. биол. наук, лаборатория биохимического гомеостаза

197022, Санкт-Петербург. ул. Л. Толстого, д. 17, корп. 54Тел.: +7(812)3386901 

Evdokia O. Bogdanova, PhD in Biology, Laboratory of Biochemical Homeostasis

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(812)3386901 

evdokia.bogdanova@gmail.comhttps://orcid.org/0000-0001-8024-2904ЛевыкинаЕ. Н.Levy`kinaE. N.

Левыкина Елена Николаевна, канд. хим. наук, лаборатория биохимического гомеостаза

197022, Санкт-Петербург. ул. Л. Толстого, д. 17, корп. 54Тел.: +7(812)3386901 

Elena N. Levykina, PhD in Chemistry, Laboratory of Biochemical Homeostasis

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(812)3386901 

levykinalena@mail.ruhttps://orcid.org/0000-0002-4801-3746КучерА. Г.KucherA. G.

Проф. Кучер Анатолий Григорьевич, д-р мед наук, заместитель директора

197022, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54Тел.: +7(921) 4211516 

Prof. Anatoly G. Kucher, MD, PhD, DMedSci, Research and clinical research center, vice-director

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(921) 4211516 

prof.kucher@yandex.ruНаучно-исследовательский институт нефрологии, Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. ПавловаРоссияNephrology Research Institute, Pavlov UniversityRussian Federation2020241120202462839Copyright © Воробьев Е.А., Галкина О.В., Зубина И.М., Богданова Е.О., Левыкина Е.Н., Кучер А.Г., 20202020Воробьев Е.А., Галкина О.В., Зубина И.М., Богданова Е.О., Левыкина Е.Н., Кучер А.Г.Vorobyev E.A., Galkina O.V., Zubina I.M., Bogdanova E.O., Levy`kina E.N., Kucher A.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/1899острое повреждение почекострый коронарный синдромбиомаркерыпредиктивная диагностикаacute kidney injuryacute coronary syndromebiomarkersdiagnostic techniques and proceduresРабота выполнена в рамках государственного задания, тема НИР: «Разработка подходов к предиктивной диагностике острого кардиоренального синдрома развития острого повреждения почек у пациентов с острыми коронарными синдромами».ReferencesEren Z, Ozveren O, Buvukoner E et al. A Single-Centre Study of Acute Cardiorenal Syndrome: Incidence, Risk Factors and Consequences. Cardiorenal Med 2012;2(3):168-176. doi: 10.1159/000337714Eren Z, Ozveren O, Buvukoner E et al. A Single-Centre Study of Acute Cardiorenal Syndrome: Incidence, Risk Factors and Consequences. Cardiorenal Med 2012;2(3):168-176. doi: 10.1159/000337714Pickering JW, Blunt IRH, Than MP. Acute Kidney Injury and mortality prognosis in Acute Coronary Syndrome patients: A meta-analysis. Nephrology 2018;23(3):237-246. doi: 10.1111/nep.12984Pickering JW, Blunt IRH, Than MP. Acute Kidney Injury and mortality prognosis in Acute Coronary Syndrome patients: A meta-analysis. Nephrology 2018;23(3):237-246. doi: 10.1111/nep.12984Neves D, Belo A, Damásio AF et al. Acute kidney injury in acute coronary syndromes – An important multifactorial consequence. Rev Port Cardiol 2016;35(7-8):415-421. doi: 10.1016/j.repc.2016.04.008Neves D, Belo A, Damásio AF et al. Acute kidney injury in acute coronary syndromes – An important multifactorial consequence. Rev Port Cardiol 2016;35(7-8):415-421. doi: 10.1016/j.repc.2016.04.008Marenzi G, Cosentino N, Bartorelli AL. Acute kidney injury in patients with acute coronary syndromes. Heart 2015;101(22):1778-1785. doi: 10.1136/heartjnl-2015-307773Marenzi G, Cosentino N, Bartorelli AL. Acute kidney injury in patients with acute coronary syndromes. Heart 2015;101(22):1778-1785. doi: 10.1136/heartjnl-2015-307773Rodrigues FB, Bruetto RG, Torres US et al. Effect of Kidney Disease on Acute Coronary Syndrome. Clin J Am Soc Nephrol 2010;5(8):1530-1536. doi: 10.2215/CJN.01260210Rodrigues FB, Bruetto RG, Torres US et al. Effect of Kidney Disease on Acute Coronary Syndrome. Clin J Am Soc Nephrol 2010;5(8):1530-1536. doi: 10.2215/CJN.01260210Bruetto RG, Rodrigues FB, Torres US et al. Renal Function at Hospital Admission and Mortality Due to Acute Kidney Injury after Myocardial Infarction. Gupta V, ed. PLoS ONE 2012;7(4):e35496. doi: 10.1371/journal.pone.0035496Bruetto RG, Rodrigues FB, Torres US et al. Renal Function at Hospital Admission and Mortality Due to Acute Kidney Injury after Myocardial Infarction. Gupta V, ed. PLoS ONE 2012;7(4):e35496. doi: 10.1371/journal.pone.0035496AlFaleh HF, Alsuwaida AO, Ullah A et al. The prognostic impact of in-hospital worsening of renal function in patients with acute coronary syndrome. Int J Cardiol 2013;167(3):866-870. doi: 10.1016/j.ijcard.2012.01.097AlFaleh HF, Alsuwaida AO, Ullah A et al. The prognostic impact of in-hospital worsening of renal function in patients with acute coronary syndrome. Int J Cardiol 2013;167(3):866-870. doi: 10.1016/j.ijcard.2012.01.097Rangaswami J, Bhalla V, Blair JEA et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 2019;139(16). doi: 10.1161/CIR.0000000000000664Rangaswami J, Bhalla V, Blair JEA et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 2019;139(16). doi: 10.1161/CIR.0000000000000664Takahama H, Kitakaze M. Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets. Am J Physiol-Heart Circ Physiol 2017;313(4):H715-H721. doi: 10.1152/ajpheart.00215.2017Takahama H, Kitakaze M. Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets. Am J Physiol-Heart Circ Physiol 2017;313(4):H715-H721. doi: 10.1152/ajpheart.00215.2017Смирнов АВ. Системный подход к анализу кардиоренальных взаимоотношений как первых шаг на пути к нефрологии формата П4. Нефрология 2011;15(2):11-19. doi: 10.24884/1561-6274-2011-15-2-11-19Smirnov AV. Systematic approach to the analysis of cardiorenal relations as a first step towards nephrology P4 format. Nephrology (Saint-Petersburg) 2011;15(2):11-19. (In Russ.) doi: 10.24884/1561-6274-2011-15-2-11-19Bouquegneau A, Krzesinski J-M, Delanaye P et al. Biomarkers and physiopathology in the cardiorenal syndrome. Clin Chim Acta 2015;443:100-107. doi: 10.1016/j.cca.2014.10.041Bouquegneau A, Krzesinski J-M, Delanaye P et al. Biomarkers and physiopathology in the cardiorenal syndrome. Clin Chim Acta 2015;443:100-107. doi: 10.1016/j.cca.2014.10.041Ronco C, Cicoira M, McCullough PA. Cardiorenal Syndrome Type 1. J Am Coll Cardiol 2012;60(12):1031-1042. doi: 10.1016/j.jacc.2012.01.077Ronco C, Cicoira M, McCullough PA. Cardiorenal Syndrome Type 1. J Am Coll Cardiol 2012;60(12):1031-1042. doi: 10.1016/j.jacc.2012.01.077Ortega-Hernández J, Springall R, Sanchez-Munoz F et al. Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function. BMC Cardiovasc Disord 2017;17(1):202. doi: 10.1186/s12872-017-0640-0Ortega-Hernández J, Springall R, Sanchez-Munoz F et al. Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function. BMC Cardiovasc Disord 2017;17(1):202. doi: 10.1186/s12872-017-0640-0Reinstadler SJ, Kronbichler A, Reindl M et al. Acute kidney injury is associated with microvascular myocardial damage following myocardial infarction. Kidney Int 2017;92(3):743-750. doi: 10.1016/j.kint.2017.02.016Reinstadler SJ, Kronbichler A, Reindl M et al. Acute kidney injury is associated with microvascular myocardial damage following myocardial infarction. Kidney Int 2017;92(3):743-750. doi: 10.1016/j.kint.2017.02.016Yu J, Oh PC, Kim M et al. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. Taniyama Y, ed. PLOS ONE 2017;12(8):e0182829. doi: 10.1371/journal.pone.0182829Yu J, Oh PC, Kim M et al. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. Taniyama Y, ed. PLOS ONE 2017;12(8):e0182829. doi: 10.1371/journal.pone.0182829Tung YC, Chang CH, Chen YC et al. Combined Biomarker Analysis for Risk of Acute Kidney Injury in Patients with STSegment Elevation Myocardial Infarction. Duffield JS, ed. PLOS ONE 2015;10(4):e0125282. doi: 10.1371/journal.pone.0125282Tung YC, Chang CH, Chen YC et al. Combined Biomarker Analysis for Risk of Acute Kidney Injury in Patients with STSegment Elevation Myocardial Infarction. Duffield JS, ed. PLOS ONE 2015;10(4):e0125282. doi: 10.1371/journal.pone.0125282Thygesen K, Alpert JS, Jaffe AS et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 2018;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038Thygesen K, Alpert JS, Jaffe AS et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 2018;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci 2019;20(8):1820. doi: 10.3390/ijms20081820Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci 2019;20(8):1820. doi: 10.3390/ijms20081820Aimo A, Januzzi JL, Bayes-Genis A et al. Clinical and Prognostic Significance of sST2 in Heart Failure. J Am Coll Cardiol 2019;74(17):2193-2203. doi: 10.1016/j.jacc.2019.08.1039Aimo A, Januzzi JL, Bayes-Genis A et al. Clinical and Prognostic Significance of sST2 in Heart Failure. J Am Coll Cardiol 2019;74(17):2193-2203. doi: 10.1016/j.jacc.2019.08.1039Huang WP, Zheng X, He L et al. Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction. Chinese medical journal 2018;131(11):1282-1288. doi: 10.4103/0366-6999.232819Huang WP, Zheng X, He L et al. Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction. Chinese medical journal 2018;131(11):1282-1288. doi: 10.4103/0366-6999.232819Chatterjee S, Kundu A, Mukherjee D et al. Risk of contrastinduced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data: Acute kidney injury with multi-vessel intervention. Catheter Cardiovasc Interv 2017;90(2):205-212. doi: 10.1002/ccd.26928Chatterjee S, Kundu A, Mukherjee D et al. Risk of contrastinduced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data: Acute kidney injury with multi-vessel intervention. Catheter Cardiovasc Interv 2017;90(2):205-212. doi: 10.1002/ccd.26928Tyminska A, Kaplon-Cieslicka A, Ozieranski K et al. Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction. Dis Markers 2019;2019:1-12. doi: 10.1155/2019/9529053Tyminska A, Kaplon-Cieslicka A, Ozieranski K et al. Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction. Dis Markers 2019;2019:1-12. doi: 10.1155/2019/9529053Everett CC, Fox KA, Reynolds C et al. Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial. BMJ Open 2019;9(9):e032165. doi: 10.1136/bmjopen-2019-032165Everett CC, Fox KA, Reynolds C et al. Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial. BMJ Open 2019;9(9):e032165. doi: 10.1136/bmjopen-2019-032165Abellás-Sequeiros RA, Raposeiras-Roubin S, Abu-Assi E et al. Mehran contrast nephropathy risk score: Is it still useful 10 years later? J Cardiol 2016;67(3):262-267. doi: 10.1016/j.jjcc.2015.05.007Abellás-Sequeiros RA, Raposeiras-Roubin S, Abu-Assi E et al. Mehran contrast nephropathy risk score: Is it still useful 10 years later? J Cardiol 2016;67(3):262-267. doi: 10.1016/j.jjcc.2015.05.007Buargub M, Elmokhtar Z. Incidence and mortality of acute kidney injury in patients with acute coronary syndrome: A retrospective study from a single coronary care unit. Saudi J Kidney Dis Transplant 2016;27(4):752. doi: 10.4103/1319-2442.185238Buargub M, Elmokhtar Z. Incidence and mortality of acute kidney injury in patients with acute coronary syndrome: A retrospective study from a single coronary care unit. Saudi J Kidney Dis Transplant 2016;27(4):752. doi: 10.4103/1319-2442.185238Haase M, Müller C, Damman K et al. Pathogenesis of Cardiorenal Syndrome Type 1 in Acute Decompensated Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). In: McCullough PA, Kellum JA, Mehta RL, Murray PT, Ronco C, eds. Contributions to Nephrology. Vol 182. S. KARGER AG; 2013:99-116. doi: 10.1159/000349969Haase M, Müller C, Damman K et al. Pathogenesis of Cardiorenal Syndrome Type 1 in Acute Decompensated Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). In: McCullough PA, Kellum JA, Mehta RL, Murray PT, Ronco C, eds. Contributions to Nephrology. Vol 182. S. KARGER AG; 2013:99-116. doi: 10.1159/000349969Di Lullo L, Bellasi A, Barbera V et al. Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate. Indian Heart J 2017;69(2):255-265. doi: 10.1016/j.ihj.2017.01.005Di Lullo L, Bellasi A, Barbera V et al. Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate. Indian Heart J 2017;69(2):255-265. doi: 10.1016/j.ihj.2017.01.005

The authors declare that there are no conflicts of interest present.